Written answers

Tuesday, 20 November 2018

Photo of James BrowneJames Browne (Wexford, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

416. To ask the Minister for Health the number of times the rare disease technology review committee has met; the name of each member; and if he will make a statement on the matter. [47996/18]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.

Photo of James BrowneJames Browne (Wexford, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

417. To ask the Minister for Health the number of drugs considered by the rare disease technology review committee; the names of the drugs; and if he will make a statement on the matter. [47997/18]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

Comments

No comments

Log in or join to post a public comment.